BUDAPEST, HUNGARY and LONDON and PRINCETON, NJ--(Marketwire - July 31, 2009) -
| Highlighted Links |
http://thalesnano.com |
http://flowreact.com |
"With rapid growth comes the need for additional senior leadership to guide ThalesNano and maintain our world leadership position. We are delighted to have Dominic on board and his skills have already had a significant impact on our direction and operations," said Dr. Ferenc Darvas, Founder and Chairman of ThalesNano Inc.
"ThalesNano is an amazing company that perfectly balances disruptive innovation with solutions that have immediate impact on discovery results and the bottom line of world's largest, pharmaceutical, fine chemical, and petroleum companies, as well as academic research institutions," said Dominic Gallello. "It is a delight to work with such a talented team that is transforming chemistry."
In addition to his Board responsibilities, Mr. Gallello leads key aspects of the company's operations including sales & marketing and the product delivery process.
About ThalesNano Inc.:
ThalesNano is a world-leading provider of continuous process chemistry
instruments in the rapidly developing market of laboratory and process
scale flow reactors. The company has the widest portfolio of bench-top
continuous process instruments. Its R&D 100 award winning H-Cube®
continuous-flow hydrogenation reactor and the pilot plant scale version
H-Cube Midi™ are used in hundreds of laboratories in four continents and
have become the new industry standard for hydrogenation. 20 out of 20 of
the largest pharmaceutical companies in the world employ ThalesNano
products and technologies.
